- Home
- CMND vs DSS Comparison
CMND vs DSS Comparison
Compare CMND & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- DSS
- Stock Information
- Founded
- CMND 2017
- DSS 1984
- Country
- CMND Canada
- DSS United States
- Employees
- CMND N/A
- DSS N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- CMND Health Care
- DSS Consumer Discretionary
- Exchange
- CMND Nasdaq
- DSS Nasdaq
- Market Cap
- CMND 7.5M
- DSS 7.3M
- IPO Year
- CMND N/A
- DSS N/A
- Fundamental
- Price
- CMND $1.49
- DSS $0.86
- Analyst Decision
- CMND
- DSS
- Analyst Count
- CMND 0
- DSS 0
- Target Price
- CMND N/A
- DSS N/A
- AVG Volume (30 Days)
- CMND 2.9M
- DSS 36.0K
- Earning Date
- CMND 01-28-2025
- DSS 11-13-2024
- Dividend Yield
- CMND N/A
- DSS N/A
- EPS Growth
- CMND N/A
- DSS N/A
- EPS
- CMND N/A
- DSS N/A
- Revenue
- CMND N/A
- DSS $25,019,000.00
- Revenue This Year
- CMND N/A
- DSS N/A
- Revenue Next Year
- CMND N/A
- DSS N/A
- P/E Ratio
- CMND N/A
- DSS N/A
- Revenue Growth
- CMND N/A
- DSS N/A
- 52 Week Low
- CMND $0.92
- DSS $0.81
- 52 Week High
- CMND $2.30
- DSS $2.30
- Technical
- Relative Strength Index (RSI)
- CMND 52.63
- DSS 42.21
- Support Level
- CMND $1.41
- DSS $0.89
- Resistance Level
- CMND $1.62
- DSS $0.99
- Average True Range (ATR)
- CMND 0.13
- DSS 0.08
- MACD
- CMND 0.00
- DSS -0.00
- Stochastic Oscillator
- CMND 33.33
- DSS 0.00
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.